Cargando…
Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches
The coronavirus is a group of viruses found in animals as well as humans and have been detected since the 1960s. However, a newly identified form, SARS-CoV-2, has triggered a recent pandemic of respiratory disease now called COVID-19. There is currently no specific antiviral drug for the treatment o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAAB. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437493/ https://www.ncbi.nlm.nih.gov/pubmed/32839635 http://dx.doi.org/10.1016/j.sajb.2020.07.035 |
_version_ | 1783572636239921152 |
---|---|
author | Dwarka, Depika Agoni, Clement Mellem, John Jason Soliman, Mahmoud E Baijnath, Himansu |
author_facet | Dwarka, Depika Agoni, Clement Mellem, John Jason Soliman, Mahmoud E Baijnath, Himansu |
author_sort | Dwarka, Depika |
collection | PubMed |
description | The coronavirus is a group of viruses found in animals as well as humans and have been detected since the 1960s. However, a newly identified form, SARS-CoV-2, has triggered a recent pandemic of respiratory disease now called COVID-19. There is currently no specific antiviral drug for the treatment of this pandemic, with most treatment strategies focused on symptomatic management and supportive therapy. As such, several drug discovery efforts are ongoing for potent treatment agents, with medicinal plants gradually gaining prominence. Approximately 80% of the South African population use traditional medicines to meet their primary health care needs. The current study aimed to identify potential COVID-19 therapeutic agents from a list of 29 bioactive compounds isolated from commonly used South African medicinal plants using molecular docking and molecular dynamics. Molecular docking identified arabic acid from Acacia senegal and L-canavanine found in Sutherlandia frutescens as a potential inhibitor of SARS-CoV-2 3C-like main protease. Similarly, hypoxoside isolated from Hypoxis hemerocallidea and uzarin from Xysmalobium undulatum, were identified as a potential inhibitor of SARS-CoV-2 receptor binding domain and SARS-CoV-2 RNA-dependent polymerase. These four bioactive compounds exhibited favourable binding orientations characterized by strong molecular interactions within respective inhibitors binding pockets of the target enzymes. Molecular dynamics simulations revealed that the binding of the identified inhibitors are characterized by structural perturbations which favour the inhibitory potency of these bioactive compounds. Additionally, in silico pharmacokinetic assessment of the compounds demonstrated favourable anti-SARS-CoV-2 properties. Although not conclusive, further experimental exploration of these compounds could serve as a starting point for the discovery of novel SARS-CoV-2 therapeutic. |
format | Online Article Text |
id | pubmed-7437493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAAB. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74374932020-08-20 Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches Dwarka, Depika Agoni, Clement Mellem, John Jason Soliman, Mahmoud E Baijnath, Himansu S Afr J Bot Article The coronavirus is a group of viruses found in animals as well as humans and have been detected since the 1960s. However, a newly identified form, SARS-CoV-2, has triggered a recent pandemic of respiratory disease now called COVID-19. There is currently no specific antiviral drug for the treatment of this pandemic, with most treatment strategies focused on symptomatic management and supportive therapy. As such, several drug discovery efforts are ongoing for potent treatment agents, with medicinal plants gradually gaining prominence. Approximately 80% of the South African population use traditional medicines to meet their primary health care needs. The current study aimed to identify potential COVID-19 therapeutic agents from a list of 29 bioactive compounds isolated from commonly used South African medicinal plants using molecular docking and molecular dynamics. Molecular docking identified arabic acid from Acacia senegal and L-canavanine found in Sutherlandia frutescens as a potential inhibitor of SARS-CoV-2 3C-like main protease. Similarly, hypoxoside isolated from Hypoxis hemerocallidea and uzarin from Xysmalobium undulatum, were identified as a potential inhibitor of SARS-CoV-2 receptor binding domain and SARS-CoV-2 RNA-dependent polymerase. These four bioactive compounds exhibited favourable binding orientations characterized by strong molecular interactions within respective inhibitors binding pockets of the target enzymes. Molecular dynamics simulations revealed that the binding of the identified inhibitors are characterized by structural perturbations which favour the inhibitory potency of these bioactive compounds. Additionally, in silico pharmacokinetic assessment of the compounds demonstrated favourable anti-SARS-CoV-2 properties. Although not conclusive, further experimental exploration of these compounds could serve as a starting point for the discovery of novel SARS-CoV-2 therapeutic. SAAB. Published by Elsevier B.V. 2020-09 2020-08-19 /pmc/articles/PMC7437493/ /pubmed/32839635 http://dx.doi.org/10.1016/j.sajb.2020.07.035 Text en © 2020 SAAB. Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Dwarka, Depika Agoni, Clement Mellem, John Jason Soliman, Mahmoud E Baijnath, Himansu Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches |
title | Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches |
title_full | Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches |
title_fullStr | Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches |
title_full_unstemmed | Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches |
title_short | Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches |
title_sort | identification of potential sars-cov-2 inhibitors from south african medicinal plant extracts using molecular modelling approaches |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437493/ https://www.ncbi.nlm.nih.gov/pubmed/32839635 http://dx.doi.org/10.1016/j.sajb.2020.07.035 |
work_keys_str_mv | AT dwarkadepika identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches AT agoniclement identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches AT mellemjohnjason identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches AT solimanmahmoude identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches AT baijnathhimansu identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches |